A Retrospective Multicenter Study of the Artelon® Carpometacarpal Joint Implant

Bell, Robert S.; Desai, Sanjay S.; House, Hugh O.; OʼDonovan, Terrence M.; Palmer, Andrew K.

doi:10.1007/s11552-011-9366-0

Cited by 9 publications

(6 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results are substantially worse than previously published (Bell et al, 2011;Blount et al, 2013;Clarke et al, 2011;Jorheim et al, 2009;Nilsson et al, 2005Nilsson et al, , 2010Park et al, 2012;Richard et al, 2014). Nilsson et al (2010) suggested that with preoperative antibiotics, complications can be avoided, yet all our patients received pre-and postoperative antibiotics.…”

contrasting

confidence: 84%

“…The few existing studies showed diverse results. While some of the studies demonstrate very good results with improved thumb function (Bell et al, 2011;Diao, 2009; Park et al, 2012), other studies showed high complication rates (Blount et al, 2013;Clarke et al, 2011;Jorheim et al, 2009;Richard et al, 2014;Robinson and Muir, 2011). We report our results in 14 patients with painful thumb carpo-metacarpal joint osteoarthritis (OA) (Eaton and Littler Stages 3 and 4) or isolated scaphotrapezio-trapezoid (STT) OA surgically treated by implantation of an Artelon spacer.…”

mentioning

confidence: 93%

See 1 more Smart Citation

Poor outcomes from use of the Artelon® biodegradable implant for the treatment of thumb carpo-metacarpal joint and scapho-trapezio-trapezoid osteoarthritis: a short report and brief review of literature

Ehrl¹,

Erne²

2015

J Hand Surg Eur Vol

View full text Add to dashboard Cite

contrasting

confidence: 84%

mentioning

confidence: 93%

Poor outcomes from use of the Artelon® biodegradable implant for the treatment of thumb carpo-metacarpal joint and scapho-trapezio-trapezoid osteoarthritis: a short report and brief review of literature

Ehrl¹,

Erne²

2015

J Hand Surg Eur Vol

View full text Add to dashboard Cite

“…3,4 Later reviews described good outcome with improved pinch and tripod grip but high complication rates due to painful foreign body synovitis which required removal of implant if the pain persisted. [5][6][7][8][9] Comparative studies of the use of the biodegradable Artelon spacer with a simple trapeziectomy or LRTI procedure showed symptomatic improvement in both groups, with higher morbidity in the interposition arthroplasty group due to synovitis and ongoing pain. 3,[10][11][12][13] The article reporting on outcomes of the bioabsorbable RegJoint showed improved pain and increased strength at a mean of 3-year follow-up.…”

Section: Resultsmentioning

confidence: 99%

“…Comparative studies between an LRTI procedure and partial trapezial excision and interposition arthroplasty performed with the PyroDisk implant and early results of the Artelon implant and autologous tendon graft, as well as a comparative study of the use of OrthoADAPT, GraftJacket, and Artelon, show pain relief, functional improvement, and patient satisfaction, although none of the interposition materials were superior to the other. 1-21,32 Closer assessment shows that pain improvement and patient satisfaction were lower in the Artelon group, despite improved pinch and tripod grip, compared with the trapeziectomy and LRTI group. 12…”

Section: Discussionmentioning

confidence: 99%

“…31,32,34 Our review of only stage II to III disease treated with partial resection and interposition arthroplasty shows that revision rates vary, being highest at 14% to 15% with Artelon and RegJoint due to pain, swelling, and signs of inflammation due to foreign body reactions and synovitis during implant degradation. [4][5][6][7][8][9][10]23,32 Osteolysis was noted in some cases of synovitis with the use of Artelon. 11,12 Revision surgery for the PyroDisk implant due to ongoing pain and instability was performed within 2 years of implant insertion.…”

Section: Durability and Revisionmentioning

confidence: 99%

See 1 more Smart Citation

Systematic Review of Thumb Carpometacarpal Joint Hemiresection Interposition Arthroplasty Materials

Spiteri

Giele

2020

Hand (New York, N,Y.)

View full text Add to dashboard Cite

Background Osteoarthritis of the first carpometacarpal joint is a common condition. Various management options and surgical procedures have been described to treat symptomatic cases. Many systematic reviews examine aspects of thumb carpometacarpal joint osteoarthritis treatment, although none solely examines the outcomes of trapezial partial resection and interposition arthroplasty in stage II to III patients in detail, yet this technique is of growing interest as surgeons seek more nuanced, tailored approaches for osteoarthritis of the first carpometacarpal joint. Methods A systematic review of the thumb carpometacarpal joint hemiresection and interposition arthroplasty was performed with pain assessment as a primary outcome measure and patient-reported outcome measures (PROMs) and reoperation rate as secondary outcome measures. A search was performed between 2004 and 2019 using MEDLINE, Embase, and PubMed. Preferred Reporting Items and Systematic Reviews and Meta-Analyses guidelines were used. Results Twenty-nine articles met the inclusion criteria and were included in the final review. Pain relief and improved PROMs were described in all the articles using this technique with all the interposition materials. Materials such as polyurethane urea matrix and poly-l/d-lactide scaffold had higher complication rates. Revision rates varied and were highest with the polyurethane urea matrix. Conclusions This review shows that hemiresection interposition arthroplasty is a useful technique and provides symptomatic benefit in patients with Eaton-Littler stage II and III osteoarthritis. Revision surgery rates due to persistent pain and instability were higher with the use of implants. Larger and long-term studies of this technique using autologous or more bioinert materials and implants are required to assess duration of symptomatic benefit.

show abstract

Endoprothetik am Daumensattelgelenk

2016

View full text Add to dashboard Cite

The role of joint replacement in the treatment of osteoarthritis of the thumb carpometacarpal joint is a subject of considerable controversy in the current literature. In German-speaking countries this technique is used much less frequently than resection procedures. Aseptic loosening of the prosthesis is believed to be the major cause of the high failure rates reported for cemented and uncemented types of implants. In this study the different implant designs were evaluated on the basis of the results reported in the international literature. There are only a few studies that cover relatively long follow-up periods and provide convincing results for thumb carpometacarpal joint prostheses in terms of implant survival and function. Aseptic loosening is reported to be the major cause with failure rates of 50 % or more. Although a Norwegian study reported high 5 and 10-year survival rates for various thumb carpometacarpal joint prostheses according to the Norwegian arthroplasty registry, it did not recommend the widespread use of thumb carpometacarpal joint replacement at the present time. In our opinion, joint replacement may be considered as a possible treatment option for advanced osteoarthritis of the thumb carpometacarpal joint but it should not always be recommended because long-term results are inconsistent and similar functional outcomes have been reported for alternative surgical techniques, such as resection arthroplasty.

show abstract

A Retrospective Multicenter Study of the Artelon® Carpometacarpal Joint Implant

Abstract: At a follow-up period of 4 years, patients had measured improvement as well as positive self-reported functional improvements following Artelon® implant insertion for the treatment of arthritis of the thumb CMCJ.

Cited by 9 publications

References 31 publications

Poor outcomes from use of the Artelon® biodegradable implant for the treatment of thumb carpo-metacarpal joint and scapho-trapezio-trapezoid osteoarthritis: a short report and brief review of literature

Poor outcomes from use of the Artelon® biodegradable implant for the treatment of thumb carpo-metacarpal joint and scapho-trapezio-trapezoid osteoarthritis: a short report and brief review of literature

Systematic Review of Thumb Carpometacarpal Joint Hemiresection Interposition Arthroplasty Materials

Endoprothetik am Daumensattelgelenk

Contact Info

Product

Resources

About